Evidence map›Paper›PMID 29785566›Full record

ArticleFamilial cancer2019

Delineating a new feature of constitutional mismatch repair deficiency (CMMRD) syndrome: breast cancer.

Lisa Bush, Melyssa Aronson, Uri Tabori, Brittany B Campbell, Raymond B Bedgood, Kory Jasperson

Abstract readCase Reports
PubMed Publisher
In one paragraph

Article in Familial cancer, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 6 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Lisa BushHereditary Cancer Program, Northside Hospital Cancer Institute, 1100 Johnson Ferry Rd NE, Atlanta, GA, 30342, USA. lisa.bush@northside.com.ORCID http://orcid.org/0000-0001-9997-8276
Melyssa AronsonZane Cohen Centre for Digestive Diseases, Mount Sinai Hospital, University of Toronto, 60 Murray Street, Toronto, ON, M5T 3L9, Canada.
Uri TaboriDivision of Haematology/Oncology, The Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, ON, M5G 1X8, Canada.
Brittany B CampbellProgram in Genetics and Genome Biology, The Hospital for Sick Children, University of Toronto, 686 Bay Street, 17-9420Y, Toronto, ON, M5G 0A4, Canada.
Raymond B BedgoodGastroenterology Associates of Central Georgia, 610 Third Street, Suite 202, Macon, GA, 31201, USA.
Kory JaspersonDepartment of Medical Affairs, Ambry Genetics, 15 Argonaut, Aliso Viejo, CA, 92656, USA.
University of Toronto · CAAmbry Genetics (United States) · USMount Sinai Hospital · CANorthside Hospital · US

Funding

CIHR
6 · The paper itself

Abstract

Constitutional mismatch repair deficiency (CMMRD) syndrome is a rare autosomal recessive hereditary cancer condition, characterized by an exceptionally high risk of cancer, a propensity for childhood malignancies, and cutaneous features reminiscent of neurofibromatosis type 1 (NF1). We report on two sisters originally suspected of having CMMRD syndrome due to their history of colonic polyps and NF1 associated skin findings, both were subsequently found to have biallelic MSH6 mutations. After years of CMMRD syndrome follow-up, the proband was diagnosed with breast cancer at age 29, while her sister was diagnosed with a glioblastoma at age 27. Immunohistochemistry analysis on the breast tumor tissue revealed weak MSH6 protein staining. Exome sequencing revealed a hypermutated breast tumor and an ultra-hypermutated brain tumor. Multi-gene panel testing was also performed and revealed no additional mutations which might explain the proband's early onset breast cancer. This is the first documented case of breast cancer in an individual with CMMRD syndrome. We summarize the evidence supporting the possible association between breast cancer and biallelic MMR mutations. Healthcare providers should be aware of this possible association and follow-up appropriately for suspicious breast findings. In addition, this case highlights the need for frequent central nervous system screenings due to rapid progression of brain tumors.

Indexed as

AdultBrain NeoplasmsBreast NeoplasmsColorectal NeoplasmsDNA-Binding ProteinsFemaleGenetic TestingHumansMutationNeoplastic Syndromes, HereditaryPedigreeYoung AdultDNA-Binding ProteinsG-T mismatch-binding proteinCMMRDConstitutional mismatch repair deficiency syndromeHereditary brain tumorHereditary breast cancerLynch syndromeMSH6

Identifiers

PMID29785566
OpenAlexW2803533503

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.